Actelion says trial drug significantly improves sleep (Reuters)

Reuters - Swiss biotech firm Actelion's
experimental sleep drug, the first of a new class of potential
medicines, significantly improved sleep for insomniacs in
mid-stage clinical trials, the company said on Sunday.

Source: http://rss.news.yahoo.com